Future of liver disease in the era of direct acting antivirals for the treatment of hepatitis C-Reference-Cited by-同舟云学术

Future of liver disease in the era of direct acting antivirals for the treatment of hepatitis C

Published:2017 Issue:7 Volume:9 Page:352
ISSN:1948-5182
Container-title:World Journal of Hepatology
language:en
Short-container-title:WJH

Author:

Ponziani Francesca Romana,Mangiola Francesca,Binda Cecilia,Zocco Maria Assunta,Siciliano Massimo,Grieco Antonio,Rapaccini Gian Lodovico,Pompili Maurizio,Gasbarrini Antonio

Publisher

Baishideng Publishing Group Inc.

Subject

Hepatology

Reference115 articles.

1. EASL Recommendations on Treatment of Hepatitis C 2015

2. Global Burden of Disease (GBD) for Hepatitis C

3. The global burden of hepatitis C

4. Armstrong GL, Wasley A, Simard EP, McQuillan GM, Kuhnert WL, Alter MJ. The prevalence of hepatitis C virus infection in the United States, 1999 through 2002. Ann Intern Med 2006;144:705-714.

5. Pathogenesis and prevention of hepatitis C virus-induced hepatocellular carcinoma

Cited by 50 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development of a Lateral Flow Assay for the Detection of the Hepatitis C Virus Core Antigen;Pharmaceuticals;2024-08-04

2. Production and characterization of monoclonal antibodies for the detection of the hepatitis C core antigen;Frontiers in Molecular Biosciences;2023-07-13

3. Systemic treatment in patients with Child–Pugh B liver dysfunction and advanced hepatocellular carcinoma;Cancer Medicine;2023-05-10

4. Diagnostic performance of hepatitis C core antigen assay to identify active infections: A systematic review and meta‐analysis;Reviews in Medical Virology;2023-02-22

5. Epidemiology and management of hepatitis B and C in primary care in the Netherlands: data from the Rijnmond Primary Care database;Family Practice;2022-07-23